Not counting his re-nomination hearings, Greenspan testified an average of more than 10 times per year between 2000 and 2005.
FORBES: Magazine Article
2.
Keen observers should compare the roster of this new committee to the 2010 hearings to determine which participants have been re-invited and which have not.
FORBES: Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings